A detailed history of Duncker Streett & CO Inc transactions in Haleon PLC stock. As of the latest transaction made, Duncker Streett & CO Inc holds 83 shares of HLN stock, worth $779. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83
Holding current value
$779
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$8.32 - $10.7 $690 - $888
83 New
83 $0
Q4 2023

Jan 30, 2024

BUY
$7.78 - $8.62 $225 - $249
29 New
29 $0

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Duncker Streett & CO Inc Portfolio

Follow Duncker Streett & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duncker Streett & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Duncker Streett & CO Inc with notifications on news.